000			01591cam a22003858i 4500
999			_c59107 _d59107
001			19420750
005			20180716132830.0
008			161223s2017 nyua g b 001 0 eng
010			_a 2016059298
020			_a9781119289746 (pbk.)
020			_z9781119289753 (Adobe PDF)
020			_z9781119289784 (epub)
035			_a(DNLM)101697888
040			_aDNLM/DLC _cDLC _erda
042			_apcc
050	0	0	_aRM302.5
060	1	0	_aQV 771
082	0	0	_a615.7042 _223 _bW I
100	1		_aWaller, Patrick, _d1957 January 30- _eauthor.
245	1	3	_aAn introduction to pharmacovigilance / _cPatrick Waller, Mira Harrison-Woolrych.
250			_a2nd edition.
260			_aNew York : _bJohn Wiley & Sons Ltd, _c2017.
263			_a1707
265			_aالمكتبة الاكاديمية
300			_a170 p. ; _c23 cm.
504			_aIncludes bibliographical references and index.
505	0		_aWhat is pharmacovigilance and how has it developed? -- Basic concepts -- Types and sources of data -- The process of pharmacovigilance -- Regulatory aspects of pharmacovigilance -- International collaboration -- Clinical aspects of adverse drug reactions -- Ethical and societal considerations -- Future directions -- Learning more about pharmacovigilance.
650	1	2	_aPharmacovigilance
650	2	2	_aDrug Monitoring _xmethods
650	2	2	_aDrug-Related Side Effects and Adverse Reactions
650	2	2	_aPharmaceutical Preparations _xstandards
700	1		_aHarrison-Woolrych, Mira, _eauthor.
906			_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg
942			_2ddc _cBK _iFOP _6FOP